Active Stocks
Tue May 21 2024 15:59:52
  1. Tata Steel share price
  2. 174.30 3.81%
  1. NTPC share price
  2. 371.90 1.50%
  1. Power Grid Corporation Of India share price
  2. 325.45 2.71%
  1. Tata Motors share price
  2. 951.15 -0.19%
  1. State Bank Of India share price
  2. 830.55 1.18%
Business News/ News / India/  Patanjali case: Setback to Baba Ramdev as Uttarakhand govt suspends licences of THESE 14 products | Here's why
BackBack

Patanjali case: Setback to Baba Ramdev as Uttarakhand govt suspends licences of THESE 14 products | Here's why

The Uttarakhand government's drug licensing authority has suspended licences of at least 14 products manufactured by Patanjali's Divya Pharmacy. This is yet another setback to yoga guru Baba Ramdev amid row over misleading ads

A hoarding with an image of Baba Ramdev is seen inside a Patanjali store. (File Photo: Reuters)Premium
A hoarding with an image of Baba Ramdev is seen inside a Patanjali store. (File Photo: Reuters)

In yet another setback for yoga guru Baba Ramdev amid the ongoing row over misleading ads, the Uttarakhand government has suspended licences of at least 14 products manufactured by Patanjali's Divya Pharmacy.

The action by the Uttarakhand government comes days after Baba Ramdev and his associate Acharya Balkrishna issued an apology in newspapers after the Supreme Court's tongue-lashing.

The products have been suspended with immediate effect, and the order was issued earlier this month.

Also Read: Baba Ramdev 'crossed red line' with false COVID cure claims, people believed him: IMA chief on confronting Patanjali

The list of suspended products

Among the products that have been suspended are: Swasari Gold, Swasari Vati, Bronchom, Swasari Pravahi, Swasari Avaleha, Mukta Vati Extra Power, Lipidom, BP Grit, Madhugrit and Madhunashini Vati Extra Power, 'Livamrit Advance', 'Livogrit', 'Eyegrit Gold' and 'Patanjali Drishti Eye Drop',

Reason behind the action

The drug licensing authority suspended the licences of the products by the firm due to violations of the Drugs and Magic Remedies (Objectionable Advertisements) Act and the Drugs and Cosmetic Act.

The firm did not provide the information sought regarding the products, and the explanation offered in defence was not satisfactory, the authority said in its order, news wire PTI reported quoting the order.

Apology for misleading ads

On April 16, during the contempt case hearing against Patanjali Ayurved, Ramdev, and Balkrishna, they apologized to the Supreme Court for publishing misleading advertisements.

On April 23, the Supreme Court asked Patanjali's lawyers to bring on record a copy of the apology advertisements.

The case related to the apology published will be heard in the Supreme Court on Tuesday, April 30.

Also Read: IMA demands action against Ramdev for making unscientific statements against allopathy

"Baba Ramdev crossed the red line"

Meanwhile, speaking to PTI, Indian Medical Association president Dr R V Asokan said that Baba Ramdev crossed a red line when he claimed he could cure Covid-19 and at the same time maligned modern medicine by calling it a "stupid and bankrupt science".

Unlock a world of Benefits! From insightful newsletters to real-time stock tracking, breaking news and a personalized newsfeed - it's all here, just a click away! Login Now!

Catch all the Business News, Market News, Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.
More Less
Published: 30 Apr 2024, 10:30 AM IST
Next Story footLogo
Recommended For You